# RUZURGI
> **NDA209321** · New Drug Application · Sponsor: JACOBUS PHARM CO INC · Approved 2022-02-01
## Drug
- **FDA Application Number:** NDA209321
- **Application type:** New Drug Application
- **Brand name:** RUZURGI
- **Generic name:** Amifampridine
- **Active ingredients:** AMIFAMPRIDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** JACOBUS PHARM CO INC
- **First approval:** 2022-02-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209321)
---
*AI Analytics · CC0 1.0*